Molecular Pharmacology of Gelsemium Alkaloids on Inhibitory Receptors
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25063390 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ana M Marileo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Biological Sciences, Universidad de Concepcion, Concepción 4070386, Chile. Hauptthemen laut MEDLINE: Gelsemium, Alkaloids. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, Millennium Nucleus for the Study of Pain (MiNuSPain), ANID-FONDECYT.
Abstract (Originalsprache)
Indole alkaloids are the main bioactive molecules of the Gelsemium genus plants. Diverse reports have shown the beneficial actions of Gelsemium alkaloids on the pathological states of the central nervous system (CNS). Nevertheless, Gelsemium alkaloids are toxic for mammals. To date, the molecular targets underlying the biological actions of Gelsemium alkaloids at the CNS remain poorly defined. Functional studies have determined that gelsemine is a modulator of glycine receptors (GlyRs) and GABAA receptors (GABAARs), which are ligand-gated ion channels of the CNS. The molecular and physicochemical determinants involved in the interactions between Gelsemium alkaloids and these channels are still undefined. We used electrophysiological recordings and bioinformatic approaches to determine the pharmacological profile and the molecular interactions between koumine, gelsemine, gelsevirine, and humantenmine and these ion channels. GlyRs composed of α1 subunits were inhibited by koumine and gelsevirine (IC50 of 31.5 ± 1.7 and 40.6 ± 8.2 μM, respectively), while humantenmine did not display any detectable activity. The examination of GlyRs composed of α2 and α3 subunits showed similar results. Likewise, GABAARs were inhibited by koumine and were insensitive to humantenmine. Further assays with chimeric and mutated GlyRs showed that the extracellular domain and residues within the orthosteric site were critical for the alkaloid effects, while the pharmacophore modeling revealed the physicochemical features of the alkaloids for the functional modulation. Our study provides novel information about the molecular determinants and functional actions of four major Gelsemium indole alkaloids on inhibitory receptors, expanding our knowledge regarding the interaction of these types of compounds with protein targets of the CNS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Biological Sciences, Universidad de Concepcion, Concepción 4070386, Chile.
- Millennium Nucleus for the Study of Pain (MiNuSPain), Santiago 8331150, Chile.
ORCID-Profile: Ana M Marileo, Patricio A Castro, Luis G Aguayo, Gustavo Moraga-Cid, Carlos F Burgos
Förderung
- Agencia Nacional de Investigación y Desarrollo
- Millennium Nucleus for the Study of Pain (MiNuSPain)
- ANID-FONDECYT
- ANID doctoral fellowship
Zitieren
APA
Marileo, A. M., Lara, C. O., Sazo, A., Contreras, O. V., González, G., Castro, P. A., Aguayo, L. G., Moraga-Cid, G., Fuentealba, J., Burgos, C. F., & Yévenes, G. E. (2024). Molecular Pharmacology of Gelsemium Alkaloids on Inhibitory Receptors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063390
Vancouver
Marileo AM, Lara CO, Sazo A, Contreras OV, González G, Castro PA, et al. Molecular Pharmacology of Gelsemium Alkaloids on Inhibitory Receptors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063390
BibTeX
@article{Marileo2024,
author = {Marileo, Ana M and Lara, César O and Sazo, Anggelo and Contreras, Omayra V and González, Gabriel and Castro, Patricio A and Aguayo, Luis G and Moraga-Cid, Gustavo and Fuentealba, Jorge and Burgos, Carlos F and Yévenes, Gonzalo E},
title = {Molecular Pharmacology of Gelsemium Alkaloids on Inhibitory Receptors},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25063390}
}
EUVIMED